Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTR-601 in Cervical Dystonia
NCT06830642Phase 2Terminated
- Sponsor
- Motric Bio
- Start
- Feb 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MPH-220 in cervical dystonia (CD), sponsored by Motric Bio. Started Feb 2025; status: terminated.
02
Drugs
MPH-220
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT06830642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06830642.